Skip to content

FDA and Social Media

In the last few weeks, I’ve given several presentations to European pharma companies about what kind of strategy they should endorse in order to use social media properly. And when it comes to regulations, we are all in trouble, because without exact answers, it’s hard to implement any kind of strategies. But now!

On November 12-13, the FDA will hold a hearing on how pharmaceutical companies use the web and social-media tools to market their products  the first step to providing guidelines around this type of marketing. Sixty-two speakers from pharmaceutical companies, media companies, agencies, and others have been asked to give their viewpoints.

The reason why I’m writing about it is the perfect online coverage of the event. See FDASM for more details:

fdasm

About these ads

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 38,241 other followers

%d bloggers like this: